From the miRoncol archive: This update is presented in its original historical context. Current platform and product information is available throughout the main website.
We are thrilled to announce the establishment of miRoncol’s Scientific Advisory Board in October 2023. This group of experts is dedicated to guiding our mission of revolutionizing cancer detection and democratizing access to early detection with accurate, affordable multi-cancer early blood tests.
Our board members include:
- Beth Rogozinski, CEO, Oncoustics
- Jiah Pearson-Leary, PhD, CEO, Spire Bio Advisory
- Vinona Bhatia, MD, MPH, Principal, Atapir
- Hallgeir Rui, MD, PhD, Professor, Thomas Jefferson University
- Jerry Lee, PhD, Professor, University of Southern California
Their collective expertise and vision will be instrumental in advancing miRoncol’s groundbreaking work.